SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-005948
Filing Date
2022-02-01
Accepted
2022-02-01 17:08:49
Documents
1
Period of Report
2022-01-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3429
  Complete submission text file 0001209191-22-005948.txt   4810
Mailing Address 15279 ALTON PARKWAY SUITE 100 IRVINE CA 92618
Business Address
MCGINLEY KATHLEEN (Reporting) CIK: 0001280509 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36152 | Film No.: 22580041

Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Issuer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)